Patients to understand more about their genetic health through HIPPA Compliant GeneFAX™ ChatBOT on just a click
San Jose, CA, March 30, 2020: OptraHEALTH®, creators of GeneFAX™, the conversational AI platform trained on genetics and AdvaGenix, which provides advanced genetic testing for your family's diagnostic, reproductive, cancer, and proactive health care, announced today that Advagenix has implemented GeneFAX™ to assist their patients with accurate information about genetic health.
GeneFAX™, a flagship product of OptraHEALTH, is an AI-powered HIPAA compliant, knowledge platform for genetic health with BOT interfaces. By employing this AI-enabled technology BOT, AdvaGenix will collect information about their patients’ family history of cancer as well as understanding reproductive health issues. Patients will then get automatically directed to the right tests to AdvaGenix through GeneFAX™.
“There has been a heavy focus on enabling direct-to-consumer genetic testing over the last few years, but we cannot forget that most of this testing is still being ordered in a clinic. We want to make sure that physicians, genetic labs and patients are at the center of everything we develop,” said Dr. Gauri Naik, CoFounder & Chief Executive Officer, OptraHEALTH. “GeneFAX™, our quality-assured, HIPAA compliant knowledge platform will assist AdvaGenix to better engage with their patients for Hereditary Cancer & Reproductive Genetic Health diagnostic testing and promote their testing panels in appropriate healthcare settings.”, she further added.
The value of the GeneFAX™ platform is in the “layer” of AI technology that brings together the key components required to simplify patient screening and family history collection processes. These components include direct integrations into genetic testing laboratories, on-demand genetic counseling services, integrations into electronic health records, patient engagement tools, patient triaging tools, and digital representation of patient health data.
"Implementing machine learning techniques to tackle the vast amount of patient data that must be collected and analyzed helps cut down on costs for researchers and clinicians. Physicians are also looking for ways to educate patients on appropriate genetic tests. The techniques and platforms offered by GeneFAX are made available on AdvaGenix web portal that improves the efficiency of the clinical workflow process and enhances the accessibility of genomic information to individuals interested in learning more about how their genetic makeup may impact their health.," said Dr. William Kearns, President & Chief Scientific Officer, AdvaGenix.
OptraHEALTH® is focused on improving outcomes for consumers and leading Life Sciences and Healthcare organizations by utilizing our next-generation Artificial Intelligence Platform. OptraHEALTH’s flagship product GeneFAX™ is an AI-powered Knowledge Platform for Genetic Health and is available as a Web Plugin or Mobile application.
About AdvaGenix. Rockville Maryland
AdvaGenix is focused on specialized genetic testing for whole genomes, clinical exomes, gene panels, and chromosomes. AdvaGenix also offers TaqPath COVID-19 Combo Kit: Multiplex assay for COVID-19. AdvaGenix employs next-generation sequencing using our NovaSeq 6000, Sanger sequencing for confirmation testing and capillary electrophoresis for gene expansion diagnostics. We also perform qPCR. AdvaGenix also provides testing for research labs across the country from DNA extraction, to library prep to whole genome / exome sequencing. We also provide the most advanced bioinformatics platform to detect, annotate and classify genomic variants associated with multiple disorders, including oncology for patients with active cancers, hereditary cancer, cardiology, metabolism, pediatric disorders, and many others.
Media Inquiries Contacts:
For Optra Health